111 (YI) Income from Non-Controlling Interests (2017 - 2025)
111 (YI) reported Income from Non-Controlling Interests of $30000.0 for Q4 2025, down 97.52% on a YoY basis from $1.2 million in Q4 2024, and down 90.26% sequentially from $308000.0 in Q3 2025.
111 (YI) Income from Non-Controlling Interests (2017 - 2025) Analysis & Trends
111 (YI) has 9 years of Income from Non-Controlling Interests data on file, last reported at $30000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Non-Controlling Interests fell 97.52% year-over-year to $30000.0; the trailing twelve-month figure through Dec 2025 stood at $571000.0 (down 50.56% YoY), and the FY2025 full-year result was -$585000.0, up 49.17% from the prior year.
- Income from Non-Controlling Interests eased to $30000.0 in Q4 2025, from $308000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $3.9 million in Q2 2021 to a low of -$152000.0 in Q2 2024.
- A 5-year average of $780000.0 and a median of $509000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests surged 7818.37% in 2021 and plunged 151.88% in 2024, its largest moves.
- Tracing YI's Income from Non-Controlling Interests over 5 years: stood at $712000.0 in 2021, then fell by 23.03% to $548000.0 in 2022, then soared by 131.02% to $1.3 million in 2023, then slipped by 4.42% to $1.2 million in 2024, then plunged by 97.52% to $30000.0 in 2025.
- Business Quant data shows YI's Income from Non-Controlling Interests at $30000.0 in Q4 2025, $308000.0 in Q3 2025, and -$7000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 173.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -11.80 Mn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -19.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 5.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 30,000.00 |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | - |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 308,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | -152,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | 293,000.00 |
| Mar 31, 2023 | 204,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 521,000.00 |
| Mar 31, 2022 | 706,000.00 |
| Dec 31, 2021 | 712,000.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 3.49 Mn |